Elizabeth Garrett-Mayer to Biomarkers
This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about Biomarkers.
Connection Strength
0.046
-
Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C18-ceramide as a novel biomarker for monitoring response. Clin Cancer Res. 2011 Sep 15; 17(18):6097-105.
Score: 0.016
-
Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast. Carcinogenesis. 2007 Jul; 28(7):1485-90.
Score: 0.012
-
A large high-density lipoprotein enriched in apolipoprotein C-I: a novel biochemical marker in infants of lower birth weight and younger gestational age. JAMA. 2005 Apr 20; 293(15):1891-9.
Score: 0.010
-
Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood. Exp Hematol. 2002 Jul; 30(7):816-23.
Score: 0.008